Dr. Mascarenhas on the Benefit of Fedratinib in Myelofibrosis

Press/Media

Period	9 Mar 2023

Media coverage

Title	Dr. Mascarenhas on the Benefit of Fedratinib in Myelofibrosis
Media name/outlet	OncLive
Country/Territory	United States
Date	9/03/23
URL	ct.moreover.com/?a=50207995803&p=1gw&v=1&x=X6Z9in7JED8WBDdEs045hw
Persons	John Mascarenhas